By Oliver Hirt and Noele Illien ZURICH (Reuters) – Since UBS rescued its stricken rival Credit Suisse a year ago, it has been waiting to hear how authorities will protect Switzerland from the ri[...]
Read more
April 8, 2024
Stock moves suggest belief in ‘no landing’ economy, Morgan Stanley says
By Lewis Krauskopf NEW YORK (Reuters) – Recent action in the U.S. stock market suggests investors are beginning to price in a “no landing” economic scenario that involves an expected[...]
Read more
JPMorgan CEO Dimon hails US power in policy-focused letter to investors
By Nupur Anand NEW YORK (Reuters) -JPMorgan Chase CEO Jamie Dimon hailed U.S. leadership and economic power in an annual letter to shareholders on Monday that invoked “liberty and justice for al[...]
Read more
Exclusive-Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial
By Marisa Taylor WASHINGTON (Reuters) – Synchron Inc, a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to[...]
Read more
Shell looking at all options including New York listing, Bloomberg Opinion says
(Reuters) -Oil major Shell is looking at “all options” including switching its listing to New York from London, according to comments made by the company’s CEO in a piece published b[...]
Read more
Factbox-Key executives and potential CEO candidates at JPMorgan
By Nupur Anand and Lananh Nguyen NEW YORK (Reuters) -JPMorgan Chase’s board is spending “significant” time on developing executives viewed as strong contenders to succeed CEO Jamie D[...]
Read more
Tradeweb to buy investment tech firm ICD for $785 million
By Niket Nishant (Reuters) -Rates and credit trading platform Tradeweb Markets will buy investment technology firm Institutional Cash Distributors (ICD) for $785 million, it said on Monday, as it seek[...]
Read more
Analysis-Google’s contemplated mega deal would prompt new fight with regulators
By Milana Vinn and Anirban Sen (Reuters) -Google parent Alphabet’s contemplated acquisition of marketing software company HubSpot would likely spark opposition from regulators even as many exper[...]
Read more
Novo Nordisk parent refiles US application on Catalent deal
COPENHAGEN (Reuters) – The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S. Federal Trade Commission (FTC) for approval of a $16.5 billion deal to buy manufacturing[...]
Read more